Venous thromboembolism in hospitalized coronavirus disease 2019 patients stratified by vaccination status.
作者信息
Bozzani Antonio, Cutti Sara, Arici Vittorio, Ragni Franco, Sterpetti Antonio V, Arbustini Eloisa
机构信息
Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
出版信息
J Vasc Surg Venous Lymphat Disord. 2023 Mar;11(2):473-474. doi: 10.1016/j.jvsv.2022.10.011.
Abstract
摘要
相似文献
1
Venous thromboembolism in hospitalized coronavirus disease 2019 patients stratified by vaccination status.按疫苗接种状态分层的2019冠状病毒病住院患者的静脉血栓栓塞症
J Vasc Surg Venous Lymphat Disord. 2023 Mar;11(2):473-474. doi: 10.1016/j.jvsv.2022.10.011.
2
Which are the optimal thromboprophylaxis strategies for hospitalized patients with COVID-19? current controversies.对于 COVID-19 住院患者，最佳的血栓预防策略是什么？当前存在争议。
Vascular. 2024 Feb;32(1):220-225. doi: 10.1177/17085381221126235. Epub 2022 Sep 8.
3
Impact of vaccination status and anticoagulation on venous thromboembolism risk and outcomes in coronavirus disease 2019 patients.疫苗接种状况和抗凝治疗对2019冠状病毒病患者静脉血栓栓塞风险及预后的影响
J Vasc Surg Venous Lymphat Disord. 2023 Mar;11(2):474-475. doi: 10.1016/j.jvsv.2022.10.012.
4
A matter of time: duration and choice of venous thromboprophylaxis in patients diagnosed with COVID-19.时间问题：COVID-19确诊患者静脉血栓预防的持续时间和选择
Br J Hosp Med (Lond). 2020 May 2;81(5):1-2. doi: 10.12968/hmed.2020.0210. Epub 2020 May 18.
5
Venous thromboembolism in patients with COVID-19 infection: risk factors, prevention, and management.新型冠状病毒肺炎感染患者的静脉血栓栓塞症：危险因素、预防和管理。
Semin Vasc Surg. 2021 Sep;34(3):101-116. doi: 10.1053/j.semvascsurg.2021.06.002. Epub 2021 Aug 4.
6
COVID-19 thromboembolism is reduced in ambulatory, but not hospitalized patients, following COVID-19 vaccination.新冠病毒疫苗接种后，门诊患者的新冠病毒病血栓栓塞情况有所减轻，但住院患者并非如此。
Haematologica. 2023 Sep 1;108(9):2503-2506. doi: 10.3324/haematol.2022.282262.
7
PERTinent new insights into venous thromboembolism risk and management in hospitalized patients with COVID-19.关于新冠肺炎住院患者静脉血栓栓塞风险及管理的相关新见解。
Vasc Med. 2021 Aug;26(4):434-436. doi: 10.1177/1358863X211012776. Epub 2021 May 20.
8
Anticoagulant Therapy in COVID-19 Associated Venous Thromboembolism: A Pivotal Risk Factor.新冠病毒感染相关静脉血栓栓塞症的抗凝治疗：一个关键危险因素
Angiology. 2024 Oct;75(9):899. doi: 10.1177/00033197231224484. Epub 2023 Dec 26.
9
[Recommendations for the use of thromboprophylaxis in hospitalized patients with COVID-19 in Argentina].[阿根廷COVID-19住院患者血栓预防用药建议]
Medicina (B Aires). 2020;80 Suppl 3:65-66.
10
Acute venous thromboembolism after COVID-19 vaccination.新冠病毒疫苗接种后的急性静脉血栓栓塞症
J Vasc Surg Venous Lymphat Disord. 2022 Jan;10(1):285. doi: 10.1016/j.jvsv.2021.08.024.
引用本文的文献
1
Does COVID-19 vaccination protect against pulmonary embolism?新冠病毒疫苗接种能否预防肺栓塞？
J Anesth Analg Crit Care. 2023 May 30;3:14. doi: 10.1186/s44158-023-00097-4. eCollection 2023.
2
Impact of vaccination status and anticoagulation on venous thromboembolism risk and outcomes in coronavirus disease 2019 patients.疫苗接种状况和抗凝治疗对2019冠状病毒病患者静脉血栓栓塞风险及预后的影响
J Vasc Surg Venous Lymphat Disord. 2023 Mar;11(2):474-475. doi: 10.1016/j.jvsv.2022.10.012.
本文引用的文献
1
Characteristics and outcomes of vaccinated and nonvaccinated patients hospitalized in a single Italian hub for COVID-19 during the Delta and Omicron waves in Northern Italy.在意大利北部，针对德尔塔和奥密克戎变异株流行期间，于单一意大利 COVID-19 中心住院的接种疫苗患者和未接种疫苗患者的特征和结局。
Int J Infect Dis. 2022 Sep;122:420-426. doi: 10.1016/j.ijid.2022.06.028. Epub 2022 Jun 22.
2
Low-molecular-weight heparin compared with unfractionated heparin in critically ill COVID-19 patients.低分子肝素与普通肝素在危重症 COVID-19 患者中的比较。
J Vasc Surg Venous Lymphat Disord. 2022 Sep;10(5):1128-1136. doi: 10.1016/j.jvsv.2022.04.019. Epub 2022 Jun 15.
3
COVID-19-related thrombotic complications experience before and during delta wave.新冠病毒相关血栓性并发症在德尔塔变异株流行前后的发病情况
J Vasc Surg. 2022 Nov;76(5):1374-1382.e1. doi: 10.1016/j.jvs.2022.04.053. Epub 2022 Jun 11.
4
Therapeutic Anticoagulation with Heparin in Patients with Covid-19.新冠病毒病患者使用肝素进行治疗性抗凝
N Engl J Med. 2021 Nov 18;385(21):2013-2014. doi: 10.1056/NEJMc2115560.
5
Incidence and effects of deep vein thrombosis on the outcome of patients with coronavirus disease 2019 infection.新冠肺炎感染患者深静脉血栓形成的发生率及其对结局的影响。
J Vasc Surg Venous Lymphat Disord. 2022 Jul;10(4):803-810. doi: 10.1016/j.jvsv.2021.10.013. Epub 2021 Nov 11.
6
A simple prognostic score for COVID-19 hospitalized patients developing deep vein thrombosis.用于预测 COVID-19 住院患者发生深静脉血栓的简单预后评分。
Phlebology. 2021 Dec;36(10):835-840. doi: 10.1177/02683555211030099. Epub 2021 Jul 2.
7
Acute arterial and deep venous thromboembolism in COVID-19 patients: Risk factors and personalized therapy.新型冠状病毒肺炎患者的急性动脉和深静脉血栓栓塞症：危险因素和个体化治疗。
Surgery. 2020 Dec;168(6):987-992. doi: 10.1016/j.surg.2020.09.009. Epub 2020 Sep 22.
Zotero 插件